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Abstract
Purpose The relationship between quality of life, psy-
chological distress, and orofacial syndromes in children
and adolescents has been reported in several studies.
However, little is known about differences in psychological
distress and quality of life among adults with different
orofacial conditions. Therefore, the aims of this study were
to examine and compare these factors among three groups
of adults affected by Treacher Collins syndrome (TCS),
cherubism, and oligodontia/ectodermal dysplasia (ED).
Methods We included 11 individuals with TCS (mean
age 46.9, SD 12.9 years), 15 with cherubism (mean age
50.3, SD 16.8 years), and 49 with oligodontia/ED (mean
age 30.7, SD 15.6 years). The respondents completed
questionnaires related to psychological distress and quality
of life.
Results The oligodontia/ED group had a significantly
higher level of anxiety and worse mental health-related
quality of life than both the TCS and cherubism groups.
Adults with TCS reported the highest level of depression,
and the lowest levels of overall quality of life, well-being,
and physical health-related quality of life. The cherubism
group displayed the best overall quality of life, well-being,
and mental health.
Conclusions Psychological distress and quality of life
differed in various orofacial conditions. This study pro-
vided insight into these aspects that may contribute to
improved care.
Keywords Psychological distress  Quality of life 
Treacher Collins syndrome  Cherubism  Oligodontia/
ectodermal dysplasia
Introduction
Treacher Collins syndrome (TCS), cherubism, oligodontia,
and ectodermal dysplasias (EDs) are all examples of rare
genetic conditions that affect the orofacial complex. These
conditions may affect the head, face, mouth, or neck
region, and they may influence both appearance and
function. The types of tissues affected and the level of
severity vary among different diagnoses, and also among
different individuals with the same diagnosis. Aberrations
may also be found in organs other than the orofacial
complex.
TCS is a rare autosomal-dominant condition, mainly
caused by mutations in the TCOF1 gene. The suggested
minimal criteria for the diagnosis are downward-slanting
palpebral fissures and hypoplasia of the zygomatic arches
[1]. Other frequent findings include hypoplasia of the
mandible, cleft palate, lower eyelid coloboma, microtia,
atresia of the ear canal, and hearing loss. No study has
reported an association between the locations of the
mutations and the expression of the TCS phenotype [1, 2].
It is estimated that 60 % of cases arise from de novo
mutations [3]. Identical mutations in the same family may
cause variable expressivity, and there are indications of
increased severity over generations [1]. Generally, there is
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need of management strategies lack multidisciplinary fol-
low-up and treatment planning for respiration, hearing,
skeletal growth, and orthodontic issues [4]. Recent findings
have indicated that adults with TCS may require multi-
disciplinary health services due to persistent sleep apnea,
compromised oral health, and speech deficits [5–9].
Cherubism is a rare autosomal-dominant condition
caused by mutations in the SH3BP2 gene [10]. It is char-
acterized by symmetrical enlargement of the jaws in chil-
dren, caused by the replacement of bone with fibrous tissue,
which results in a rounded face. In the most severe cases,
the orbital floor is affected, which results in upward-looking
eyes; these features give the appearance of a cherub, as
depicted in baroque paintings. Missing teeth, displaced
teeth, and premature tooth loss are additional characteristics
[11–13]. Diagnosis is typically based on a combination of
clinical, radiographic, histological, and molecular findings,
combined with a positive family history. The condition,
which is normally painless, typically presents around
3 years of age. The facial swelling increases until puberty
[14] and then slowly resolves. According to Meng et al.
[15], the facial contours are often unremarkable on clinical
examination by the age of 30 years. However, some cases
do not resolve with age [13]. According to a recent review
article [16], surgical treatment (curettage, contouring, or
resection) is not indicated in mild cases, but may be nec-
essary after puberty in moderate cases, during puberty in
severe cases, or earlier when severe functional problems are
present. Other treatment options, like medication with cal-
citonin and interferon, may be useful in the future.
The term oligodontia describes the congenital absence of
six or more permanent teeth, third molars excluded [17].
Oligodontia is associated with a delay in the development of
other teeth and a relative lack of alveolar growth. Most
individuals with oligodontia do not have other medical
symptoms or findings [18]. Oligodontia is common in many
forms of ED. The EDs comprise a large, clinically and eti-
ologically heterogeneous group of genetic disorders; at least
186 distinct pathological conditions have been recognized
[19]. No universally accepted classification for EDs has been
achieved, but the clinical classification proposed by Freire-
Maya [20] is widely used. It is based on the ‘‘classical signs’’
of ED, as follows: (group A) abnormalities in hair, teeth, nail,
and sweat glands (two findings or more) and (group B)
defects in one of the mentioned structures, plus at least one
other ectodermal defect. Individuals with EDs may exhibit
deviations in orofacial functions such as chewing, swal-
lowing, and speech [21]. The orofacial symptoms of EDs
overlap with those of oligodontia. Both conditions may alter
appearance, and salivary secretion is often reduced [22, 23].
The etiologies of the conditions are also overlapping,
because the gene mutations that cause full blown EDs may
also cause isolated oligodontia [23]. Oral treatment may be
challenging, and evaluation by a multidisciplinary team is
frequently necessary for optimal treatment planning for
individual patients. Achieving an ideal occlusion is not
always possible [24].
Former studies on psychological distress and quality of
life (QoL) associated with orofacial disorders have mostly
focused on children and adolescents. Facial appearance
after reconstructive surgery in TCS was shown to have a
direct positive influence on psychosocial factors [25], as
well as the researchers reported that some children with
TCS showed elevated anxiety compared to unaffected
children [25]. Another study demonstrated that TCS was
associated with increased social anxiety and dissatisfaction
[26]. In studies among children and adolescents with EDs,
those aged 15–19 years showed worse oral health-related
QoL in the subscale ‘‘functional limitations,’’ compared to
those aged 10–14 years. Moreover, females experienced
more emotional problems than males [27]. In children with
hypohidrotic forms of ED, QoL was influenced most by the
reduced sweating [28]. Hypodontia, per se, has been found
to impact QoL in children, because it results in functional
limitations, which reduce social and emotional well-being
[29]. In adults, QoL was most affected by actual symptoms
and findings of EDs, and the emotional and social conse-
quences had less impact [28]. Physical attractiveness is
known to contribute to a positive self-concept and social
well-being [26, 30–33]. In the worst cases of EDs, the face
has an edentulous appearance, which can lead to consid-
erable psychological disturbance [34].
To our knowledge, few researchers have examined
psychological distress and QoL in adults with orofacial
disfigurements, and no studies have compared adults
affected by different conditions. Therefore, this study aimed
to examine and describe differences in psychological dis-
tress and QoL between groups of individuals affected by
TCS, cherubism, and oligodontia/EDs. We hypothesized
that living with facial disfigurement would affect QoL,
well-being, and mental health. In light of the differences in
congenital orofacial disfigurements, we anticipated that the
TCS group may experience more psychological distress and
worse QoL than the other two groups.
Materials and methods
Participants
TCS
Between December 2008 and May 2009, we invited all
individuals with TCS that had registered at the National
Resource Centre for Oral Health in Rare conditions
(TAKO-center), the Centre for Rare Disorders (SSD), and
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the Craniofacial team at Oslo University Hospital, Riks-
hospitalet (n = 36) to participate in a study. The study
included an extensive health examination and the comple-
tion of questionnaires on psychological distress and QoL [6,
7]. Twenty-three individuals (64 %) with TCS accepted the
invitation. Of these, 10 participants were under 18 years of
age, and therefore, they were not included in this part of the
study. Two of the remaining 13 responders were excluded,
due to an unconfirmed TCS diagnosis [7]. Thus, this study
included a total of 11 adults (65 %) aged[18 years. Among
these, four had mild and seven had severe TCS phenotypes,
according to the severity scoring system developed by Teber
et al. [1, 7]. Eight participants had undergone reconstructive
surgery in the eye, ear, and/or zygomatic regions [6]; six
participants had received orthodontic treatment. Seven
patients presented with moderate to profound hearing
impairments [8]. Polysomnography demonstrated sleep
apnea in all eleven participants [7]. Facial asymmetry was
identified by assessing orofacial function with the Nordic
Orofacial Test Screen (NOT-S) [6]. Minor speech aberra-
tions were common [8].
Cherubism
We previously identified 28 individuals in Norway with
cherubism. They were partly known at the TAKO-centre
(15) or through family members (6) and partly recruited by
contacting all oral and maxillofacial surgeons and orth-
odontists in Norway (7). Of these 28 patients, 26 underwent
genetic screening, and 24 tested positive for mutations in
SH3BP2. Among these individuals with genetically verified
cherubism, 22 participated in a study where they had pro-
vided a patient history and attended oral, clinical, and
radiologic examinations. They also completed forms for
assessing psychological distress and QoL. All participants
underwent a full day of examinations, interviews, and clin-
ical genetics consultations in Oslo between September 2009
and December 2011 [13]. Of these 22 individuals, 15 (68 %)
were aged[18 years and were included in the present study.
Many of these patients had received extensive surgical and
dental treatments; 13 patients had undergone one or more
surgical procedures for tooth removal, exposure, or trans-
plantation; curettage of intra-bony soft tissue; or contouring;
11 patients had tooth replacements (removable or fixed
dentures or dental implants).
Oligodontia/ED
All individuals aged 16 years or older that had registered
with ED and/or oligodontia at the TAKO-centre were
invited to participate in a multidisciplinary study that
included questionnaires on QoL and psychological distress.
Out of 54 responders (66 %), 49 (91 %) were aged
C18 years and were included in this study. All individuals
lacked a minimum of six teeth, excluding third molars.
Other affected ectodermal tissues included skin (n = 27;
55.1 %), hair (n = 20; 40.8 %), nails (n = 19; 38.8 %),
and sweat glands (n = 10; 20.4 %). In the oligodontia/ED
group, 33 of 49 adults had received tooth replacements.
Demographics
We recorded demographic characteristics including age,
family situation, educational level, and work status.
Psychological distress
Hospital anxiety and depression scale (HADS)
The HADS measures self-reported levels of distress [35]. It
was originally developed to identify cases of anxiety and
depression among patients in non-psychiatric hospitals
[36]. It is a 14-item questionnaire with two subscales:
anxiety (HADS-A) and depression (HADS-D). Each sub-
scale has seven items rated on a 4-point Likert-style scale
from 0 (not present) to 3 (maximally present). The HADS-
A and HADS-D score sums ranged from 0 to 21. Based on
receiver operating characteristics, a sum C8 on each sub-
scale was used as a cutoff score to identify cases of pos-
sible anxiety and depression disorders, which may require
further clinical examination [35, 37]. A previous study
demonstrated that the psychometric properties of the Nor-
wegian version of the HADS were excellent [38].
Quality of life
Overall quality of life
Cantril’s Self-Anchoring Ladder (CL) is a self-adminis-
tered questionnaire that assesses overall QoL with one
question: ‘‘How is your life?’’. It asks respondents to rate
their present experiences with life on a scale anchored by
their own identified values. The response alternatives are
between 0 and 10, with 0 = worst possible QoL and
10 = best possible QoL [39].
The psychosocial well-being questionnaire, or Kaasa’s
test, assesses psychosocial experience of well-being. It
consists of five positive and five negative statements, rated
from 1 (highest QoL) to 5 (lowest QoL) [40]. In addition, the
test includes two single items of overall QoL, happiness and
satisfaction, with the ranges of 1 (highest) to 7 (lowest).
Health-related quality of life
The Short Form 36 (SF-36) [41] is a multipurpose, generic,
self-administered, health-related QoL questionnaire. It
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includes 36 items rated on eight scales (aggregating 2–10
items each) and the two summary measures Physical
Component Scale (PCS) and Mental Component Scale
(MCS). The four PCS scales are physical functioning (PF),
role limitation owing to physical health problems (RP),
bodily pain (BP) which addresses the degree of pain inter-
fering with participation in various activities of everyday
life, and general health (GH).The vitality (VT), social
functioning (SF), role limitations due to emotional problems
(RE), and mental health (MH) comprise the MCS scale.
According to standard SF-36 scoring, all information
was transformed to a scale of 0 (worst) to 100 (best). Based
on T-transformations, both PCS and MCS have a mean of
50 and a standard deviation of 10 in the US general pop-
ulation. An individual with a score \40 on both PCS and
MCS is defined as a case of poor QoL that requires treat-
ment or help in improving the QoL [41]. The SF-36 scale
has been extensively validated [42, 43].
Statistics
Significant differences between groups in demographic
variables, psychological distress, and QoL were analyzed,
depending on the distribution of variables, with parametric
tests (t test, one-way ANOVA, pairwise comparisons with
Bonferonni test) or with nonparametric tests (Kruskal–
Wallis, Mann–Whitney U). The TCS and cherubism groups
showed normal distribution curves on all dependent vari-
ables. The oligodontia/ED group showed minor deviations
on a few of the dependent variables. However, these devi-
ations had low impact, due to the sufficiently large size of
the oligodontia/ED group; therefore, all variables were
analyzed with parametric tests. The nonparametric tests
were used for groups with small sample sizes (TCS and
cherubism groups) and when any deviations were found in
the normal distribution curves. Thus, the Kruskal–Wallis
one-way analysis of variance (ANOVA) was used to ana-
lyze between-group differences. When significant differ-
ences were found, pairwise comparisons were performed
with the Mann–Whitney U test. However, the latter test did
not affect the results; therefore, the results are presented
based on the parametric tests only. Pearson’s chi-squared
statistic was used to test for significant differences between
categorical variables. To estimate the reliability of test
scores from the scale measures for the sample of respond-
ers, we evaluated the internal consistency with Cronbach’s
coefficient a. We considered Cronbach’s coefficient a val-
ues[0.60 acceptable,[0.70 good, and[0.90 excellent. The
analyses were performed with PASW Statistics 20.0 for
Windows (SPSS Inc, Chicago, IL). The level of statistical
significance was set at p B 0.05.
Ethics
This study recruitment procedures and protocol on individ-
uals with cherubism, TCS, and oligodontia/ED were
approved by the Norwegian Regional Committee of Ethics in
Medical Research as well as the Norwegian Data Inspec-
torate at Oslo University Hospital. All participants gave
written informed consent prior to inclusion in the study.
Results
Demographics are shown in Table 1. Individuals with oli-
godontia/ED were younger than those with TCS and
cherubism, but no other significant differences were
established.
Table 1 Demographics
TCS
N = 11
Cherubism
N = 15
Oligodontia/ED
N = 49
Age, years (mean/SD) 46.8 (12.9)## 50.3 (16. 8)* 32.2 (12.9)*
Civil status, N (%)
Paired relation 7 (58) 9 (60) 20 (41)
Non-paired relation 4 (42) 6 (40) 29 (59)
Educational level, N (%)
B12 years 5 (42) 8 (53) 27 (55)
C13 years 6 (58) 7 (47) 22 (45)
Employment, N (%)
Yes 8 (67) 12 (75) 26 (53)
No 3 (33) 3 (25) 23 (47)
TCS Treacher Collins syndrome, ED ectodermal dysplasia
* p \ 0.001, significant differences between cherubism and oligodontia/ED
## p \ 0.01, significant differences between TCS and oligodontia/ED
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Psychological distress (HADS)
One-way ANOVAs revealed statistically significant dif-
ferences among the three different groups in anxiety and
depression; the Bonferonni analysis suggested that the
oligodontia/ED group had a significantly higher level of
anxiety than both the other groups. Among the three
groups, the TCS group showed the highest level of
depression (Table 2). Cronbach’s a for oligodontia/ED,
TCS, and cherubism were 0.70, 0.73, and 0.71,
respectively, for the HADS-A; and 0.73, 0.70, and 0.65,
respectively, for the HADS-D. These estimations indicated
good internal consistency.
Quality of life
Overall QoL and psychosocial well-being
Table 3 reveals that the cherubism group had significantly
better overall QoL, satisfaction, and happiness than both
Table 2 Differences in anxiety and depression across groups
TCS Cherubism Oligodontia/ED pa
Mean SD Mean SD Mean SD
HADS-A 3.18 2.71 2.46 2.11 6.96§§,### 3.73 \0.001
HADS-A cases, N (%) 1 (9) 0 25 (51)
HADS-D 4.53# 3.44 0.85 1.34 3.51# 3.47 \0.001
HADS-D cases, N (%) 1 (9) 0 6 (12)
HADS-A hospital anxiety and depression anxiety score-anxiety, HADS-D hospital anxiety and depression score-depression, TCS Treacher Collins
syndrome, ED ectodermal dysplasia
a p was based on ANOVA
# p \ 0.05; ### p \ 0.001 compared to cherubism
§§ p \ 0.01 compared to TCS
Table 3 Differences in quality
of life across groups
TCS Treacher Collins
syndrome, ED ectodermal
dysplasia
a P was based on ANOVA
Ns = nonsignificant, based on
ANOVA
* p \ 0.05; ** p \ 0.01; and
*** p \ 0.001, compared to
oligodontia/ED
# p \ 0.05; ## p \ 0.01;
### p \ 0.001, compared to
cherubism
§§ p \ 0.01; §§§ p \ 0.001,
compared to TCS
TCS Cherubism Oligodontia/ED pa
Mean SD Mean SD Mean SD
Overall quality of life
Cantril’s self-anchoring
ladder (CL)
6.36 2.58 9.00§§,** 0.86 7.37 1.94 0.002
Psychosocial well-being
Kaasa’s test
Well-being 3.76***,## 0.77 2.82 0.14 2.29 0.72 \0.001
Happiness 2.82 0.60 1.77* 0.60 2.66 1.27 0.027
Satisfaction 2.36 0.67 1.32* 1.62 2.55 1.32 0.360
Health-related quality of life
SF-36
Physical functioning 77.72*,# 19.55 92.33 14.86 91.63 14.12 0.021
Role physical 90.63 18.60 91.07 21.05 85.20 24.16 Ns
Bodily pain 30.65*,# 9.24 86.07 18.71 75.87 27.58 0.030
General health 69.36 17.57 78.88 19.30 73.97 24.23 Ns
Vitality 54.54 15.57 63.78 12.76 58.30 24.79 Ns
Social functioning 81.81 26.43 96.97 12.89 82.81 27.72 Ns
Role emotional 93.80 26.43 96.66 12.90 65.78§§§,### 18.34 \0.001
Mental health 81.09 14.43 82.20 14.67 74.45 20.16 Ns
Physical component scale
(PCS)
42.97**,## 10.30 52.1 8.56 52.93 7.92 0.003
PCS case, N (%) 4 (40) 2 (13) 5 (10)
Mental component scale (MCS) 54.20 9.55 54.29 5.42 46.24§§,## 8.26 0.001
MCS case, N (%) 1 (9) 0 11 (23)
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the TCS and oligodontia/ED groups. The poorest well-
being was found among adults with TCS.
Kaasa’s test showed good internal consistency, with
Cronbach’s a values of 0.84, 0.74, and 0.87 for TCS,
cherubism, and oligodontia/ED, respectively.
Health-related QoL
Significant differences in health-related QoL were found
among the groups in physical functioning, bodily pain,
emotional-role limitations, and in the component scores,
PCS and MCS. The TCS group showed the poorest phys-
ical functioning, bodily pain, and PCS, and the oligodontia/
ED group showed the poorest emotional-role limitations
and MCS (Table 3).
The SF-36 results showed good internal consistency,
with Cronbach’s a values between 0.72 (mental health) and
0.89 (emotional-role limitations) in the TCS group; 0.61
(bodily pain) and 0.87 (physical-role limitations) in the
cherubism group; and 0.74 (bodily pain) and 0.93 (physi-
cal-role limitations) in the oligodontia/ED group. These
values were considered acceptable in all three groups.
Discussion
To our knowledge, this was the first study to compare
psychological distress and QoL among adults with three
different genetic conditions that affected the orofacial
complex. Our main findings were that psychological dis-
tress and QoL differed among the various orofacial con-
ditions. Individuals with TCS reported the most severe
depression, the least well-being, and worst physical QoL.
On the other hand, the oligodontia/ED group showed the
highest level of anxiety and the poorest mental QoL. The
cherubism group showed the best overall QoL and expe-
rienced the most satisfaction and happiness.
Cherubism develops in childhood and improves over
time, in the sense that the condition changes to a near
normal appearance in most adults. In contrast, TCS and
oligodontia/ED are permanent states of congenital facial
disfigurement. The disfigurement in TCS is frequently
worse than that observed in oligodontia/ED. In both diag-
noses, advanced interdisciplinary surgical and dental
treatment may improve oral functions over time. For
example, the replacement of missing teeth and alveolar
bone are often performed in oligodontia/ED, and multiple
corrections of micrognathia and malocclusion are common
in TCS. However, these treatments are long-term processes
and may cause psychological burden. EDs may also be
associated with other dysfunctions, such as the lack of a
capacity to sweat, low salivary secretion, and dry eyes.
TCS is also accompanied by physical symptoms, like
reduced salivary secretion, which can affect oral health and
eating [5, 6]. In addition, TCS is characterized by con-
genital hearing loss in moderate- to-severe degree [8].
The TCS group showed significantly higher levels of
depression compared to the two other groups. Depression is
often a response to loss. For a person with orofacial dis-
figurement, loss may be related to the absence of a ‘‘nor-
mal’’ appearance. According to Hatfield and Sprecher [44],
physical appearance is important in the development of
interpersonal relationships, and physical attractiveness is
known to contribute to a positive self-concept and social
well-being [31]. Based on discussions and clinical experi-
ence, individuals with TCS, from time to time, experienced
glaring eyes and sometimes rejection, due to their facial
disfigurement. These factors may partly explain why the
TCS group experienced worse overall QoL and well-being
than the other groups. QoL factors, like satisfaction with
life, happiness, and a feeling of well-being, are subjective
terms that refer to the individual achievement of one’s
goals [45]. A gap between one’s expectations and the
reality of life may cause depression, and thereby, reduce
the QoL. The higher level of depression in the TCS group
may indicate that living with TCS includes more obstacles
to participating in everyday life than living with the other
two conditions.
It was previously reported that all adults of the current
TCS study group had obstructive sleep apnea (OSA) [7].
More than 70 % had moderate-to-severe OSA, and the
severity of OSA was significantly associated with reduced
physical health-related QoL [9]. This association may
explain the report that physical health-related QoL was
worse in the TCS group than in the oligodontia/ED and
cherubism groups.
The oligodontia/ED group showed the highest level of
anxiety. Anxiety is related to worry and uncertainty about
the future. The fact that more than 50 % of individuals with
oligodontia/ED had anxiety scores above the level that
requires treatment may provide insight into this condition.
The differences among the groups may be related to dif-
ferences in stressors; thus, adults in the oligodontia/ED
group may experience a different type of stress than adults
in the other groups. For example, many individuals with
oligodontia/ED have noticeable spaces between the teeth,
which may cause significant teasing and bullying in ado-
lescence [46]. At some stage in adulthood, these individ-
uals often undergo extensive prosthodontic treatment.
However, Norway lacks a coordinated approach for offer-
ing appropriate dental services to individuals with oligo-
dontia/ED. A qualitative study performed in Ireland has
shown that delays in completing dental treatment caused
considerable frustration in patients with oligodontia/ED
[47]. In another study that included children and adoles-
cents with TCS, the main findings showed that improved
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facial appearance after reconstructive surgery had a posi-
tive influence on psychosocial and social factors [27]. This
may also apply to adults with TCS; in most cases, the
adults in the present study had completed surgical treat-
ments, and hence, they were more likely to experience less
anxiety than individuals in the oligodontia/ED group.
In addition to the high level of anxiety, the oligodontia/
ED group presented the poorest mental health-related QoL.
This finding was consistent with results from Mehta et al.
[48], who found that emotional distress was highly pre-
valent in adults with ED. Hypodontia, per se, was found to
impact QoL in children, because it resulted in functional
limitations and reduced social and emotional well-being
[29]. Furthermore, Anweigi et al. [49] reported that non-
syndromal hypodontia had a substantial impact on oral
health-related QoL and that functional limitations
increased with age. In the present study, the mean age of
individuals in the oligodontia/ED group was significantly
younger than that of individuals in the other groups; thus, it
is possible that we may have underestimated the impact of
this condition on psychological distress and QoL.
Few studies are available that investigated psychological
distress and QoL in individuals with cherubism. In a
recently published study, Prescott et al. [13] found that QoL
among individuals with cherubism was not significantly
different from QoL in an age and gender-adjusted sample of
the general Norwegian population. In the present study,
individuals with cherubism reported the least psychological
distress and the highest level of QoL among the three
groups. Thus, we confirmed the findings from Prescott et al.
that individuals with cherubism appear to be well-adjusted
on a group level. However, it is important to offer indi-
viduals with cherubism personalized healthcare services.
One strength of this study was that we used established,
validated, self-rating measures. The three conditions stud-
ied are rare, and therefore, another strength was that we
invited all registered adult individuals with TCS and
cherubism in Norway to participate in the study. It was
relatively easy to recruit these individuals through national
registry services. Because oligodontia/ED comprises a
larger group than TCS and cherubism, treatment is offered
by many different institutions. Hence, there was no single
registry that contained a complete listing of individuals
with oligodontia/ED in Norway. All patients registered at
the TAKO-centre with oligodontia/ED were invited to
participate, and patients from all parts of Norway respon-
ded. This recruitment approach yielded an adequate sam-
ple; moreover, we assume that our findings can be
generalized to all Norwegian individuals with these con-
ditions. However, the study had some limitations. It was a
cross-sectional study; thus, our results revealed important
knowledge about various aspects of psychological distress
and QoL related to a particular disease status, but we could
not determine whether these parameters might change over
time.
Clinical implications
We found that living with orofacial disfigurement caused
psychological distress, and it reduced the QoL to varying
extents among the different groups. Social and healthcare
services should focus on alleviating the high level of
anxiety and low mental QoL in adults with oligodontia/ED;
moreover, management strategies should include genetic
counseling. In addition, healthcare services should focus on
alleviating depression and low physical QoL in individuals
with TCS.
Conclusions
This study showed that psychological distress and QoL
differed among individuals with TCS, cherubism, and oli-
godontia/ED. The oligodontia/ED group was characterized
by a high level of anxiety and reduced mental QoL. The
TCS group experienced a high level of depression and
reduced physical QoL. Finally, the cherubism group
experienced less psychological distress and better QoL
than the other two groups included in this study.
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